Theranautilus Secures $1.2 Mn in Seed...
19 Nov 2024
London-based Concentra Group, a unit of Select Medical, aims for a $3.30 billion valuation in its U.S. IPO, marking its entry into a market rebounding after nearly two years of inactivity.
The company plans to sell 22.50 million shares priced between $23 and $26 each, potentially raising up to $585 million, as per a regulatory filing on Monday.
U.S. IPO activity is picking up as stock markets reach record highs and the economy remains resilient despite higher interest rates, encouraging companies to proceed with listings.
Founded in 1979, Concentra is the largest provider of occupational health services in the U.S. by location count, according to its IPO prospectus.
Select Medical announced plans earlier this year to separate Concentra, resulting in two independent, publicly traded entities. Concentra will be listed on the New York Stock Exchange under the ticker symbol "CON". J.P. Morgan, Goldman Sachs, and BofA Securities are the lead underwriters for the IPO.
Chat on WhatsApp
Request a call back
